Hematopoietic Stem Cells Transplantation Market Size, Share, Growth, and Industry Analysis by Type (Stem Cell Storage and Stem Cells Consumables), By Application (Leukemia, Lymphoproliferative Disorders, Solid Tumors, and Non-Malignant Disorders), Regional Insights, and Forecast To 2032

Updated On: 08 April 2024

HEMATOPOIETIC STEM CELLS TRANSPLANTATION MARKET REPORT OVERVIEW

• 
• Request a Free sample to learn more about this report

The global hematopoietic stem cells transplantation market size is expected to be USD 2417.2 million in 2021 and the market is projected to touch USD 4468.09 million by 2032, exhibiting a Compound annual growth rate (CAGR) of 5.7 % during the forecast (2024-2032). In the market study, our analysts have considered hematopoietic stem cells transplantation players such as CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies, Vcanbio, Merck Millipore, Lonza Group, CellGenix Technologie Transfer and ThermoGenesis.

The hematopoietic stem cells transplantation market is experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.

Hematopoietic stem cell transplantation (HSCT) is now regularly used for handling patients with malicious and non-malignant syndromes of blood and the immune structure. Presently, investigators have detected that through animal lessons HSCs have the capability to form extra cells such as muscles, bone, and blood vessels. Researchers have established substantial consideration to use HSCs as a treatment. Currently, no kind of stem cell, mature, embryonic or fetal has reached such as adequate position. In recent years, the Hematopoietic stem cell transplantation market is projected to cultivate quickly in the coming years.

COVID-19 Impact: Lockdown Restrictions to Impede Market Progress

The hematopoietic stem cells transplantation market was anticipated to be forced by the COVID-19 occurrence. Since its appearance in December 2019, the COVID-19  virus has spread to approximately every nation, encouraging the World Health Organization (WHO) to proclaim it a public health emergency. The coronavirus, was recognized as the causal manager in the pneumonia circumstances. 

LATEST TRENDS

"Increasing Cases of Leukemia to Foster Market Growth"

The rising incidence of leukemia and lymphoma is projected to motivate the hematopoietic stem cells transplantation market growth in the coming years. As per the 2019 report by Leukemia and Lymphoma Society, a likely 176,200 people in the U.S. were detected with lymphoma or myeloma, leukemia, approximately 1,399,180 people were suffering from lymphoma, leukemia, or myeloma. The growing occurrence rate is projected to drive demand for hematopoietic stem cell transplantation, therefore, pushing growth of the hematopoietic stem cells transplantation market.

HEMATOPOIETIC STEM CELLS TRANSPLANTATION MARKET SEGMENTATION

• 
• Request a Free sample to learn more about this report

• By Type

Based on type; the market is divided into Stem Cell Storage and Stem Cells Consumables.

• By Application

Based on the application; the market is divided into Leukemia, Lymphoproliferative Disorders, Solid Tumors, and Non-Malignant Disorders.

DRIVING FACTORS

"Increasing Cases of Symptoms to Foster Market Growth"

Conditions, such as auto-immune diseases, blood cancer (leukemia, and lymphoma), genetic disorders, and immunodeficiency are increasing in quantity around the globe. Hematopoietic stem cell transplant (HSCT) has seen quick development to develop the typical of maintenance for numerous patients with hereditary or developed syndromes of the hematopoietic system or with chemo- radio- or, immuno- sensitive malignancies, such as leukemia, lymphoma, solid tumors, and others in last two years. An investigation directed by Worldwide Network for Blood and Marrow Transplantation (WBMT) expected that in 2019, approximately 1.5 million HSCTs were executed worldwide.

"Infrastructural Development to Promote Growth"

Another substantial aspect impelling the development rate of the hematopoietic stem cell transplantation market is the increasing healthcare spending which benefits in improving its infrastructure. Also, several government administrations objective to recover the healthcare infrastructure by growing capital and this will promote the market dynamics. Many retailers and investigation administrations are concentrating on the expansion of modified drugs that can deal with action centered on patients' requirements and inclinations. Some of the profits of modified drugs contain low risk of protected refusal, no necessity for developing stem cells, reduced requirement for anti-rejection drugs, and fewer chances of increasing GvHD. Such assistance is growing the expansion of modified drugs using mesenchymal stem cells.

RESTRAINING FACTORS

"High Cost to Hamper Market Growth"

High-cost linked with stem cell transplantation will hinder the development rate of the market. The shortage of expert authorities and absence of healthcare infrastructure in emerging countries will dare the hematopoietic stem cell transplantation market. 

HEMATOPOIETIC STEM CELLS TRANSPLANTATION MARKET REGIONAL INSIGHTS

• 
• Request a Free sample to learn more about this report

"Presence of Prominent Players to Dominate Market in North America "

 North America holds the largest part of the global hematopoietic stem cells transplantation market share. The U.S. and Canada are the important markets for hematopoietic stem cells transplantation in the region. Moreover, the presence of prominent players will further drive the market's growth rate in this region.

Asia Pacific is anticipated to have a sizable market share. India, China and Japan will be developing as possible markets. An outstanding and long term substitute to release by side effects of chemotherapy, radiotherapy and immune-sensitive malignancies is another driver for hematopoietic stem cells transplantation market.

KEY INDUSTRY PLAYERS

"Market Players to Boost Market Growth"

The report delivers information about the list of infrared heaters market players and their operations in the industry. The information is collected and reported with proper research, technological developments, acquisitions, mergers, expanding production lines, and partnerships. Other aspects examined for this market include companies producing and introducing new products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• CBR Systems (U.S.)
• China Cord Blood Corporation (Hong Kong)
• ViaCord (U.S.)
• Thermo Fisher Scientific (U.S.)
• STEMCELL Technologies (Canada)
• Vcanbio (China)
• Merck Millipore (U.S.)
• Lonza Group (Switzerland)
• CellGenix Technologie Transfer (Germany)
• ThermoGenesis (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.